Evoq Remedies Limited (BOM:543500)

Evoq Remedies Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	0.05	2.14	1.23	1.54	30.94
Cash & Short-Term Investments	0.05	2.14	1.23	1.54	30.94
Cash Growth	-97.57%	73.50%	-19.66%	-95.04%	9179.27%
Accounts Receivable	38.55	86.17	17.43	172.16	253.98
Receivables	375.08	365.28	332.78	250.85	291.33
Inventory	16.71	22.19	31.25	20.32	7.84
Other Current Assets	125.83	108.25	3.21	76.19	3.2
Total Current Assets	517.68	497.86	368.47	348.89	333.31
Property, Plant & Equipment	1.72	2.23	0.14	0.09	-
Other Long-Term Assets	-	-	-	0	-
Total Assets	519.4	500.09	368.61	348.99	333.31

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	7.64	34.97	32.83	-5.37	12.09
Accrued Expenses	6.24	3.2	0.1	0.12	4.31
Short-Term Debt	0.73	-	42.38	95.76	81.58
Current Income Taxes Payable	-	7.2	8.14	8.67	3.67
Other Current Liabilities	61.83	9.37	32.78	1.95	-
Total Current Liabilities	76.44	54.73	116.23	101.13	101.65
Total Liabilities	76.44	54.73	116.23	101.13	101.65

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	249	249	136	136	136
Additional Paid-In Capital	-	163.52	84.42	84.42	84.42
Retained Earnings	-	32.84	31.96	27.44	11.24
Comprehensive Income & Other	193.96	-	-	-	-
Shareholders' Equity	442.96	445.36	252.38	247.86	231.66
Total Liabilities & Equity	519.4	500.09	368.61	348.99	333.31

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	0.73	-	42.38	95.76	81.58
Net Cash (Debt)	-0.68	2.14	-41.15	-94.23	-50.64
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.03	0.09	-3.03	-6.93	-5.06
Filing Date Shares Outstanding	20.83	24.9	13.6	13.6	13.6
Total Common Shares Outstanding	20.83	24.9	13.6	13.6	13.6
Working Capital	441.24	443.13	252.24	247.76	231.66
Book Value Per Share	21.27	17.89	18.56	18.22	17.03
Tangible Book Value	442.96	445.36	252.38	247.86	231.66
Tangible Book Value Per Share	21.27	17.89	18.56	18.22	17.03
Machinery	-	-	-	0.13	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error